Clinical Trial Update: A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase II open-label study of high-dose cytarabine combined with clofarabine in adults with refractory or relapsed acute myeloid leukemia or refractory/relapsed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clolar (Clofarabine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2013-02-12